MGP
ONC

M&G plc’s BeOne Medicines Ltd ONC Stock Holding History

M&G plc’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.7M Buy
223,445
+85,282
+62% +$25.1M 0.32% 76
2026
Q1 		$41M Buy
138,163
+8,372
+6% +$2.71M 0.21% 89
2025
Q4 		$39.5M Buy
129,791
+9,070
+8% +$2.97M 0.2% 95
2025
Q3 		$41.2M Sell
120,721
-49,481
-29% -$15M 0.22% 94
2025
Q2 		$41.2M Sell
170,202
-15,829
-9% -$3.88M 0.23% 96
2025
Q1 		$50.6M Sell
186,031
-7,132
-4% -$1.67M 0.24% 77
2024
Q4 		$35.7M Buy
193,163
+20,088
+12% +$4.1M 0.22% 99
2024
Q3 		$38.9M Sell
173,075
-6,704
-4% -$1.21M 0.14% 106
2024
Q2 		$25.7M Sell
179,779
-10,277
-5% -$1.58M 0.1% 123
2024
Q1 		$29.6M Buy
+190,056
New +$30.6M 0.11% 105

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

M&G plc's ONC Position: Q2 2026 in Review

M&G plc increased its BeOne Medicines Ltd (ONC) stake by 62% in Q2 2026, buying an estimated $25.1M and bringing the position to 223,445 shares worth $63.7M. The position accounts for 0.32% of the portfolio, ranked #76.

M&G plc first reported a position in ONC in Q1 2024 and has held it in 10 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • M&G plc held 223,445 shares of BeOne Medicines Ltd worth $63.7M as of Q2 2026.
  • M&G plc bought 85,282 BeOne Medicines Ltd shares in Q2 2026, an estimated $25.1M.
  • BeOne Medicines Ltd made up 0.32% of M&G plc's portfolio in Q2 2026, its #76 holding.
  • M&G plc first reported a position in BeOne Medicines Ltd in Q1 2024 and has held it in 10 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.